5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide,
5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide,
AUY922,
luminespib,
NVP-AUY922,
VER 52296,
VER-52296,
VER52296,
Luminespib,
747412-49-3,
NVP-AUY922,
AUY922,
VER-52296,
AUY-922,
AUY922 (NVP-AUY922),
UNII-C6V1DAR5EB,
Luminespib (AUY-922, NVP-AUY922),
Luminespib (NVP-AUY922),
NVP-AUY 922,
5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide,
VER 52296,
C6V1DAR5EB,
CHEBI:83656,
5-[2,4-DIHYDROXY-5-ISOPROPYLPHENYL]-N-ETHYL-4-[4-(4-MORPHOLINYLMETHYL)PHENYL]-3-ISOXAZOLECARBOXAMIDE,
AK174786,
5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide,
5-[2,4-Dihydroxy-5-(1-methylethyl)phenyl]-N-ethyl-4-[4-(4-morpholinylmethyl)phenyl]-3-isoxazolecarboxamide,
5-[2,4-Dihydroxy-5-(1-Methylethyl)phenyl]-N-Ethyl-4-[4-(Morpholin-4-Ylmethyl)phenyl]isoxazole-3-Carboxamide,
Luminespib [USAN:INN],
NVR-AUY 922,
Isoxazole, 40f,
2GJ,
VER-52296/NVP-AUY922,
PubChem19135,
Luminespib (USAN/INN),
Luminespib; NVP-AUY922,
NVP-AUY922-NX,
MLS006011081,
SCHEMBL892205,
CHEMBL252164,
GTPL9261,
SCHEMBL2682235,
AUY922,NVP-AUY922,
CHEMBL3900791,
NVP-AUY922, LUMINESPIB,
BDBM20926,
CHEBI:91422,
KS-00000IAW,
EX-A611,
QCR-179,
NDAZATDQFDPQBD-UHFFFAOYSA-N,
BCPP000145,
HMS3654C15,
AOB87330,
AUY922 - NVP-AUY922,
BCP01827,
ZX-AT015684,
ABP000836,
AN-515,
MFCD14635361,
s1069,
ZINC14974931,
AKOS015966502,
AKOS026750297,
ZINC100015656,
ZINC109565971,
ACN-038313,
BCP9001007,
CS-0136,
OR16660,
RL04840,
SB16640,
NCGC00247878-01,
NCGC00387853-03,
AS-17014,
BC219616,
HY-10215,
SC-94101,
SMR004702869,
AB0008043,
AX8167191,
A9562,
FT-0700359,
SW219319-1,
X7556,
NVP-AUY922/AUY-922,VER-52296,
CAS:747412-49-3;NVP-AUY922,
D10646,
W-5583,
412D493,
J-516600,
BRD-K41859756-001-01-9,
AUY922, VER-52296, 747412-49-3,
AUY922; VER-52296; AUY 922; VER 52296; AUY-922; VER-52296,
(5Z)-N-ethyl-5-(4-hydroxy-3-isopropyl-6-oxo-cyclohexa-2,4-dien-1-ylidene)-4-[4-(morpholinomethyl)phenyl]-2H-isoxazole-3-carboxamide,
(Z)-N-ethyl-5-(4-hydroxy-3-isopropyl-6-oxocyclohexa-2,4-dien-1-ylidene)-4-(4-(morpholinomethyl)phenyl)-2,5-dihydroisoxazole-3-carboxamide,
5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide,
5-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide,
AUY-922|||NVP-AUY922|||VER-52296|||(5Z)-N-Ethyl-5-(4-hydroxy-6-oxo-3-propan-2-ylcyclohexa-2,4-dien-1-ylidene)-4-[4-(morpholin-4-ylmethyl)phenyl]-2H-1,2-oxazole-3-carboxamide,
HSP90 inhibitors,
D01NHJ,
D05BYA,
cc-237,
AUY 922,
C26H31N3O5,
CID10096043,
CID 10096043,
A4057,
A10659,
AUY922, VER-52296, NVP-AUY922,